review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.COI.2005.03.001 |
P698 | PubMed publication ID | 15886112 |
P2093 | author name string | Robert C Rickert | |
P433 | issue | 3 | |
P304 | page(s) | 237-243 | |
P577 | publication date | 2005-06-01 | |
P1433 | published in | Current Opinion in Immunology | Q15752917 |
P1476 | title | Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex | |
P478 | volume | 17 |
Q38845138 | ABO-incompatible heart transplantation |
Q33592478 | Absence of donor-specific anti-HLA antibodies after ABO-incompatible heart transplantation in infancy: altered immunity or age? |
Q37217407 | Acute antibody-mediated complement activation mediates lysis of pancreatic islets cells and may cause tissue loss in clinical islet transplantation |
Q38094250 | B-lymphocyte lineage cells and the respiratory system |
Q37128643 | C3d adjuvant activity is reduced by altering residues involved in the electronegative binding of C3d to CR2. |
Q43082920 | CD21/35 promotes protective immunity to Streptococcus pneumoniae through a complement-independent but CD19-dependent pathway that regulates PD-1 expression |
Q48158347 | CD22 Promotes B-1b Cell Responses to T Cell-Independent Type 2 Antigens. |
Q39466279 | CD22 serves as a receptor for soluble IgM. |
Q28260435 | CD22: an inhibitory enigma |
Q36939905 | Calcium signalling and cell-fate choice in B cells |
Q35013816 | Cardiomyopathy of aging in the mammalian heart is characterized by myocardial hypertrophy, fibrosis and a predisposition towards cardiomyocyte apoptosis and autophagy. |
Q33302902 | Complement C3d conjugation to anthrax protective antigen promotes a rapid, sustained, and protective antibody response |
Q36751636 | Complement-mediated activation of the adaptive immune responses: role of C3d in linking the innate and adaptive immunity |
Q39901594 | Contribution of Chinese Pekin duck complement component C3d-P29 repeats to enhancement of Th2-biased immune responses against NDV F gene induced by DNA immunization |
Q37484505 | Depletion of the C3 component of complement enhances the ability of rituximab-coated target cells to activate human NK cells and improves the efficacy of monoclonal antibody therapy in an in vivo model |
Q42510282 | Deubiquitinating enzyme CYLD regulates the peripheral development and naive phenotype maintenance of B cells |
Q39747868 | Differential phosphorylation of functional tyrosines in CD19 modulates B-lymphocyte activation |
Q45265454 | Genetic control of HgCl2-induced IgE and autoimmunity by a 117-kb interval on rat chromosome 9 through CD4 CD45RChigh T cells |
Q37788642 | Human peripheral blood B-cell compartments: a crossroad in B-cell traffic. |
Q38798777 | Impairment of Mature B Cell Maintenance upon Combined Deletion of the Alternative NF-κB Transcription Factors RELB and NF-κB2 in B Cells |
Q41780931 | Increased B cell deletion and significantly reduced auto-antibody titre due to premature expression of human complement receptor 2 (CR2, CD21). |
Q33378891 | Induction of IgG3 to LPS via Toll-like receptor 4 co-stimulation |
Q24646878 | Interaction of human complement with Sbi, a staphylococcal immunoglobulin-binding protein: indications of a novel mechanism of complement evasion by Staphylococcus aureus |
Q38757564 | Let's Tie the Knot: Marriage of Complement and Adaptive Immunity in Pathogen Evasion, for Better or Worse |
Q34025718 | Lysophosphatidic acid receptor 5 inhibits B cell antigen receptor signaling and antibody response |
Q37124913 | Melanoma Affects the Composition of Blood Cell-Derived Extracellular Vesicles |
Q37726116 | Mesenchymal stem cells infected with Mycoplasma arginini secrete complement C3 to regulate immunoglobulin production in B lymphocytes |
Q37133741 | Molecular structure and expression of anthropic, ovine, and murine forms of complement receptor type 2. |
Q91713267 | New insights into the immune functions of complement |
Q58616776 | PD-1 immunobiology in systemic lupus erythematosus |
Q37189179 | Pathogenic mechanisms of B-lymphocyte dysfunction in HIV disease |
Q38645385 | Potential Roles for C1 Inhibitor in Transplantation |
Q38738490 | Preferential association of hepatitis C virus with CD19+ B cells is mediated by complement system |
Q92000280 | Preventing abnormal NF-κB activation and autoimmunity by Otub1-mediated p100 stabilization |
Q41933450 | Protective Humoral Immunity in the CNS Requires Peripheral CD19-Dependent Germinal Center Formation Following Coronavirus Encephalomyelitis. |
Q36863774 | Regulation of VH replacement by B cell receptor-mediated signaling in human immature B cells |
Q38037801 | Regulation of humoral immunity by complement |
Q36670538 | Role of IL-21 and IL-21 receptor on B cells in HIV infection |
Q37457141 | Suppression of phosphatidylinositol 3,4,5-trisphosphate production is a key determinant of B cell anergy |
Q37979859 | T cell-B cell interactions in primary immunodeficiencies |
Q38124186 | The pivotal position of the actin cytoskeleton in the initiation and regulation of B cell receptor activation |
Q37046216 | The role of complement in the success of vaccination with conjugated vs. unconjugated polysaccharide antigen. |
Q37987129 | The role of humoral innate immunity in hepatitis C virus infection. |
Q37623820 | The structure, genetic polymorphisms, expression and biological functions of complement receptor type 1 (CR1/CD35). |
Q24624348 | Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses |
Search more.